Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prediction of LVAR and MACE in STEMI Though Plasma Multiomics Analysis
Sponsor: Beijing Anzhen Hospital
Summary
To identify plasma multi-omics biomarkers that predict left ventricular adverse remodeling (LVAR) and major adverse cardiovascular events (MACE) in patients with acute ST-segment elevation myocardial infarction, and to investigate the molecular pathways linked to LVAR and MACE.
Official title: Prediction of Left Ventricular Adverse Remodeling and Major Adverse Cardiovascular Events in Patients With Acute ST-segment Elevation Myocardial Infarction Though Plasma Multiomics Analysis
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2025-05-01
Completion Date
2027-12-31
Last Updated
2026-05-12
Healthy Volunteers
No
Conditions
Interventions
Diagnostic Test: echocardiography and blood collection
Blood samples were collected from all patients at enrollment (within 24 hours after primary PCI), at days 3-5, and at months 1, 3, and 6 after enrollment. Echocardiography was performed at enrollment (baseline, within 24-48 hours after admission), and at months 1, 3, and 6 after enrollment.
Locations (1)
Beijing Anzhen Hospital, Capital Medical University.
Beijing, Beijing Municipality, China